Therapeutic Vaccine Combination May Help Patients with Myelodysplastic Syndrome

A new study demonstrates that it is possible to vaccinate patients with MDS against a decitabine-induced antigen and that the level of induced expression is sufficient to trigger cytotoxicity in patient-derived vaccine induced T-cells.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Hematologic Malignancies Myelodysplastic Syndromes News Source Type: news